Transaction #4349 · Form 4 · 0000943819-25-000092

RESMED INC · Exercise / conversion · ResMed Common Stock

RESMED INC · Transacted November 3, 2025 · Filed November 4, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for RESMED INC records an exercise / conversion involving ResMed Common Stock on November 3, 2025. The reported quantity was 2,000. The filing date is November 4, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company
RESMED INC
Company CIK
0000943819
Security type
Non-derivative
Acquisition type
Exercise / conversion · Code M
Quantity acquired
2,000
Reported price
101.64
Reference value
203,280
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
88,745
Ownership description
Not reported
SEC acceptance time
Nov 4, 2025, 4:02 PM EST
10b5-1 indication
Indicated in filing

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

RMD · NYSE

This transaction is not mapped to a specific company listing.

Filing footnotes & remarks

F1
The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
F2
Represents date options first become exercisable. Options vest 1/3 per year.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.